STOCKSCREENR

IMUX

NASDAQ

Immunic, Inc.

$9.65+0.03(+0.31%)Mkt Cap: $95.23M

Key Stats

Market Cap

$95.23M

P/E Ratio

-1.56

EPS

$-6.20

Dividend Yield

0.00%

52-Week Range

$5.06 — $15.10

Volume

173.94K

Avg Volume

405.56K

Beta

1.37

Price Alerts for IMUX

Get alerted when IMUX hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-1.56

Forward P/E

—

PEG Ratio

-0.68

P/S (TTM)

0.00

P/B (TTM)

-277.64

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-11.98%

ROA (TTM)

-4.04%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

-0.10

Current Ratio

0.75

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.33%

EPS Growth (5Y)

+0.20%

Sales Growth (3Y)

+0.00%

Sales Growth (5Y)

+0.00%

EPS Est (This Year)

$-0.34

EPS Est (Next Year)

$-0.32

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.01

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

98.69M

Float

95.61M

Free Float %

96.88%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

IPO Date

2014-04-17

Employees

91

CEO

Daniel Vitt

Index Membership

—

Website

https://www.immunic-therapeutics.com

Immunic, Inc. (IMUX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $95.23M, a P/E ratio of -1.56, IMUX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare IMUX against other stocks using dozens of fundamental and technical filters.

Similar Stocks

CYBN

Cybin Inc.

$8.28

+1.22%

$413.02M

ARMP

Armata Pharmaceuticals, Inc.

$8.89

-10.92%

$325.67M

REPL

Replimune Group, Inc.

$2.50

-2.72%

$206.43M

NBY

NovaBay Pharmaceuticals, Inc.

$1.88

-3.59%

$50.06M

IMAB

I-Mab

$2.88

-0.69%

$235.66M

OSTX

OS Therapies Incorporated

$1.61

-5.29%

$67.68M

Frequently Asked Questions

What is Immunic, Inc.'s P/E ratio?

Immunic, Inc. (IMUX) has a trailing twelve-month (TTM) P/E ratio of -1.56. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Immunic, Inc. pay a dividend?

No, Immunic, Inc. (IMUX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Immunic, Inc.'s market cap?

Immunic, Inc. (IMUX) has a market capitalization of $95.23 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.